BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25984040)

  • 21. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum fetuin-A levels increased following parathyroidectomy in uremic hyperparathyroidism.
    Wang CC; Hsu YJ; Wu CC; Yang SS; Chen GS; Lin SH; Chu P
    Clin Nephrol; 2012 Feb; 77(2):89-96. PubMed ID: 22257538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroidectomy for tertiary hyperparathyroidism after second kidney transplantation: a case report.
    Masaki C; Ogawa S; Shima H; Banno T; Tsuyuguchi M; Nagasaka N; Tashiro M; Inoue T; Tada H; Wariishi S; Miya K; Kawahara K; Takamatsu N; Okada K; Minakuchi J
    CEN Case Rep; 2021 May; 10(2):208-213. PubMed ID: 33079356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum bone resorption markers after parathyroidectomy for renal hyperparathyroidism: correlation analyses for the cross-linked N-telopeptide of collagen I and tartrate-resistant acid phosphatase.
    Hung KC; Huang CY; Liu CC; Wu CJ; Chen SY; Chu P; Wu CC; Lo L; Diang LK; Lu KC
    ScientificWorldJournal; 2012; 2012():503945. PubMed ID: 22919331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved Control of Secondary Hyperparathyroidism in Hemodialysis Patients Switching from Oral Cinacalcet to Intravenous Etelcalcetide, Especially in Nonadherent Patients.
    Xipell M; Montagud-Marrahi E; Rubio MV; Ojeda R; Arias-Guillén M; Fontseré N; Rodas L; Vera M; Broseta JJ; Torregrosa V; Filella X; Maduell F
    Blood Purif; 2019; 48(2):106-114. PubMed ID: 30699421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients.
    Borstnar S; Erzen B; Gmeiner Stopar T; Kocjan T; Arnol M; Kandus A; Kovac D
    Transplant Proc; 2010 Dec; 42(10):4078-82. PubMed ID: 21168632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)].
    Reichel H; Braun J
    Dtsch Med Wochenschr; 2011 Jan; 136(4):123-8. PubMed ID: 21181622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism.
    de Francisco AL; Gillespie IA; Gioni I; Floege J; Kronenberg F; Marcelli D; Wheeler DC; Froissart M; Drueke TB;
    Nefrologia; 2016; 36(2):164-75. PubMed ID: 26654696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tertiary hyperparathyroidism resistant to cinacalcet treatment.
    Okada M; Tominaga Y; Izumi K; Nobata H; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Nanmoku K; Watarai T; Uchida K
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():33-7. PubMed ID: 21595850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
    Zhang Y; Lu Y; Feng S; Zhan Z; Shen H
    Ren Fail; 2019 Nov; 41(1):921-929. PubMed ID: 31573378
    [No Abstract]   [Full Text] [Related]  

  • 31. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
    Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
    J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients.
    Zhang L; Xing C; Shen C; Zeng M; Yang G; Mao H; Zhang B; Yu X; Cui Y; Sun B; Ouyang C; Ge Y; Jiang Y; Yin C; Zha X; Wang N
    Sci Rep; 2016 May; 6():26841. PubMed ID: 27231027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease.
    Konstantinidis I; Nadkarni G; Divino CM; Lapsia V
    Clin Kidney J; 2013 Jun; 6(3):277-82. PubMed ID: 26064486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic kidney disease (CKD) and bone. The clinical perspective of parathyroid interventional therapy for advanced secondary hyperparathyroidism in the era of cinacalcet HCl].
    Tominaga Y
    Clin Calcium; 2009 Apr; 19(4):545-50. PubMed ID: 19329834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
    Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Vovan C; Chazot C
    Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H; Cui Y; Xing C; Purrunsing Y; Zha X; Shen C; Zeng M; Yang G; Yu X; Zhang L; Jiang Y; Shen Z; Ma H; Yin C; Li Y; Wang N
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinacalcet hydrochloride therapy for secondary hyperparathyroidism in hemodialysis patients.
    El-Shafey EM; Alsahow AE; Alsaran K; Sabry AA; Atia M
    Ther Apher Dial; 2011 Dec; 15(6):547-55. PubMed ID: 22107691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.
    Malluche HH; Monier-Faugere MC; Wang G; Frazã O JM; Charytan C; Coburn JW; Coyne DW; Kaplan MR; Baker N; McCary LC; Turner SA; Goodman WG
    Clin Nephrol; 2008 Apr; 69(4):269-78. PubMed ID: 18397701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report.
    Takada D; Tsukamoto T; Fuse M; Kada S; Yanagita M
    BMC Nephrol; 2017 Oct; 18(1):315. PubMed ID: 29047366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.